NASDAQ:SKIN
18.34
0.11
(0.60%)
Analysis and Opinions about SKIN-Q
Signal
Opinion
Expert
Chart
BUY
BUY
June 25, 2021
A new SPAC in beauty products. In the last two months rally from under $10 to over $17. They sell their hydra-facials to health spas and dermatologist, as well as make money off retail products. They have a positive EBITDA and a veteran CEO.
Show full opinionHide full opinion
A new SPAC in beauty products. In the last two months rally from under $10 to over $17. They sell their hydra-facials to health spas and dermatologist, as well as make money off retail products. They have a positive EBITDA and a veteran CEO.
STRONG BUY
STRONG BUY
June 2, 2021
He's shilling pitching this on the show. SKIN's product is a fast, affordable and non-invasive skin treatment that clean and hydrates your skin for everyone--men, women, young and old. Company had 52% revenue compounded growth, pre-Covid and will grow higher post-Covid as people return to work. Q1 margin increased to 66%. EBITDA adjusted was $7 million vs. a $200 million loss last year. This equipment is offered in high-end spas like the Four Seasons. Costs only $200/facial, so anyone can afford it. However, SKIN isn't making money. They're seeing strong growth in Japan. This is a vanity play as we reopen and people want to meet other people. Good CEO who was the head of surgical for Baush.
Show full opinionHide full opinionHe's shilling pitching this on the show. SKIN's product is a fast, affordable and non-invasive skin treatment that clean and hydrates your skin for everyone--men, women, young and old. Company had 52% revenue compounded growth, pre-Covid and will grow higher post-Covid as people return to work. Q1 margin increased to 66%. EBITDA adjusted was $7 million vs. a $200 million loss last year. This equipment is offered in high-end spas like the Four Seasons. Costs only $200/facial, so anyone can afford it. However, SKIN isn't making money. They're seeing strong growth in Japan. This is a vanity play as we reopen and people want to meet other people. Good CEO who was the head of surgical for Baush.
WEAK BUY
WEAK BUY
June 2, 2021
The lack of profits in their track record worries him, but the strong upward movement of the chart tells him to give it the benefit of the doubt.
Show full opinionHide full opinionThe lack of profits in their track record worries him, but the strong upward movement of the chart tells him to give it the benefit of the doubt.
Showing 1 to 3
of 3 entries
- «
- ‹
- 1
- ›
- »
The Beauty Health Company(SKIN-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 3
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 3
The Beauty Health Company(SKIN-Q) Frequently Asked Questions
What is The Beauty Health Company stock symbol?
The Beauty Health Company is a American stock, trading under the symbol SKIN-Q on the NASDAQ (SKIN). It is usually referred to as NASDAQ:SKIN or SKIN-Q
Is The Beauty Health Company a buy or a sell?
In the last year, 3 stock analysts published opinions about SKIN-Q. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for The Beauty Health Company.
Is The Beauty Health Company a good investment or a top pick?
The Beauty Health Company was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for The Beauty Health Company.
Why is The Beauty Health Company stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is The Beauty Health Company worth watching?
3 stock analysts on Stockchase covered The Beauty Health Company In the last year. It is a trending stock that is worth watching.
What is The Beauty Health Company stock price?
On 2021-07-23, The Beauty Health Company (SKIN-Q) stock closed at a price of $18.34.
